FRI0258 Long-term treatment with mycophenolate versus cyclophosphamide for systemic sclerosis-associated pulmonary fibrosis: A case control retrospective study

I. Giavri; S. Panopoulos; V.K. Bournia; K. Fragiadaki; G. Trakada; C. Kostopoulos; P.P. Sfikakis

doi:10.1136/annrheumdis-2012-eular.2715

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Alerts

Scientific Abstracts

Poster Presentations

Posters

Scleroderma, myositis and related syndromes – clinical aspects and treatment

FRI0258 Long-term treatment with mycophenolate versus cyclophosphamide for systemic sclerosis-associated pulmonary fibrosis: A case control retrospective study

Log in using your username and password

Main menu

Log in using your username and password

You are here

Read the full text or download the PDF:

Log in using your username and password